UNSPSC 51281803: Epirubicin

This classification denotes an anthracycline antibiotic with the molecular formula C27H29NO11, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3Z8479ZZ5X, chemically known as 5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-beta-l-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8s-cis)- but generally known as epirubicin, which bears US NIH Compound Identifier 41867.

UNSPSC 51281803 Epirubicin is a Commodity code nominally identifying a specific chemotherapy agent, but recent state and local opportunities show little activity directly aligned with this pharmaceutical product. Instead, the opportunities tagged under this code span a broader range of pharmaceutical procurement including naloxone and safe drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing alliances, and medical and first aid supplies for emergency response. State and local governments buying under this code are primarily health agencies, emergency services departments, and multistate cooperative purchasing organizations. The issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), municipal fire departments (City of Tampa), and multistate cooperative purchasing alliances (Minnesota MMCAP). The scope of work spans pharmaceutical supply agreements, emergency medical consumables, direct-to-manufacturer prescription programs, and generic drug distribution through authorized wholesaler networks, with procurement mechanisms ranging from formal RFPs to RFIs for market intelligence.

Geographic activity centers on Florida, Texas, Minnesota, and Oregon through the MMCAP cooperative. Recent representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) soliciting 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building; the City of Tampa's Bid 26-P-00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, designated as a sheltered market opportunity for certified Small Local Business Enterprises with an estimated contract amount of $700,000; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products, with awards effective July 1, 2026, and distributed through authorized wholesalers including AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson. The Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026, due April 3, 2026) sought vendor capabilities for direct-to-manufacturer prescription programs but represents preliminary market research rather than a formal procurement commitment.